Justin Tcheugui is an Endocrinologist in Baltimore, Maryland. Dr. Tcheugui is rated as a Distinguished provider by MediFind in the treatment of Type 2 Diabetes (T2D). His top areas of expertise are Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, Type 1 Diabetes (T1D), and Gestational Diabetes.

Sherita Golden is an Endocrinologist in Baltimore, Maryland. Dr. Golden is rated as a Distinguished provider by MediFind in the treatment of Type 2 Diabetes (T2D). Her top areas of expertise are Type 1 Diabetes (T1D), Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, Obesity, and Hormone Replacement Therapy (HRT).

Dr. Sudipa Sarkar is an assistant professor of medicine at the Johns Hopkins University School of Medicine. Her areas of clinical expertise include endocrinology. She received her M.D. from Yale School of Medicine. She completed her residency in internal medicine at Yale-New Haven Hospital and performed a fellowship in endocrinology, diabetes and metabolism at Vanderbilt University Medical Center. Dr. Sarkar joined the Johns Hopkins faculty in 2017. Dr. Sarkar is rated as a Distinguished provider by MediFind in the treatment of Type 2 Diabetes (T2D). Her top areas of expertise are Type 2 Diabetes (T2D), Diabetic Retinopathy, Maturity Onset Diabetes of the Young, Diabetic Neuropathy, and Sleeve Gastrectomy.

Rozalina Mccoy is an Endocrinologist in Baltimore, Maryland. Dr. Mccoy has been practicing medicine for over 17 years and is rated as an Elite provider by MediFind in the treatment of Type 2 Diabetes (T2D). Her top areas of expertise are Low Blood Sugar, Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, and Diabetic Hyperglycemic Hyperosmolar Syndrome.

Anthony J. Harrell, M.D., practices internal medicine at Johns Hopkins Community Physicians Greater Dundalk. He received his medical degree from Meharry Medical College in Nashville, and completed his residency at Baptist Hospital in Tennessee. Dr. Harrell is rated as an Advanced provider by MediFind in the treatment of Type 2 Diabetes (T2D). His top areas of expertise are Familial Combined Hyperlipidemia, Xanthoma, Cirrhosis, and High Cholesterol.

Dr. Bennett practices all aspects of primary care medicine, including preventive care and coordiantion of care with other specialists. She has particular interests in weight management and women's health care. She sees patients at Johns Hopkins Bayview Medical Center. Dr. Bennett is an Assistant Professor in the Division of General Internal Medicine, with joint appointments at The Johns Hopkins University Bloomberg School of Public Health. Dr. Bennett is rated as an Advanced provider by MediFind in the treatment of Type 2 Diabetes (T2D). Her top areas of expertise are Obesity, Gestational Diabetes, Peripheral Artery Disease, and Type 2 Diabetes (T2D).

Mihail “Misha” Zilbermint, M.D., M.B.A., F.A.C.E. is an Associate Professor of Clinical Medicine at the Division of Endocrinology, Diabetes and Metabolism, Johns Hopkins School of Medicine. He is the Director of Endocrine Hospitalists at the Johns Hopkins Community Physicians, Chief and Director of Division of Endocrinology, Diabetes and Metabolism at Suburban Hospital in Bethesda, MD. Dr. Zilbermint is known for pioneering the Endocrine Hospitalist program at Johns Hopkins Medicine following the completion of his endocrinology fellowship at the National Institutes of Health. This consultation service is dedicated to enhancing glycemic control among hospitalized patients, effectively reducing patient stays and saving the hospital hundreds of thousands of dollars. His commitment to innovation earned his specialized diabetes team the Johns Hopkins Innovations in Clinical Care Award. Over the years, Dr. Zilbermint has been sought after for his expertise in endocrinology and diabetes, with a focus on inpatient diabetes management, diabetic ketoacidosis (DKA), Hyperosmolar Hyperglycemic State (HHS), and diabetes technology. His reputation extends nationally and internationally, as he is often invited to speak at conferences and is sought after for consultations worldwide. His extensive research interests encompass diabetes initiatives, hypoglycemia reduction, continuous glucose monitoring (CGM) systems, COVID-19 vaccines and hyperglycemia, COVID-19 and diabetes, genetic causes of hypertension, primary aldosteronism, rare adrenal tumors, and the interplay between diabetes and climate change. Dr. Zilbermint leads the JHCP Academy Clinical Excellence, which helps to recognize and promote clinical excellence about community-based clinicians. Beyond his clinical and research contributions, Dr. Zilbermint is a dedicated educator. He imparts his expertise to endocrinology fellows, hospitalists, pharmacy residents, and advanced practice providers, furthering the advancement of the medical community. CVhttps://www.hopkinsmedicine.org/-/media/profiles-support/cvs/zilbermint.pdfLinkedInhttps://www.linkedin.com/in/mishazilbermint. Dr. Zilbermint is rated as an Advanced provider by MediFind in the treatment of Type 2 Diabetes (T2D). His top areas of expertise are Cushing's syndrome, Familial Hyperaldosteronism, Hyperaldosteronism, Low Blood Sugar, and Thymectomy.

Dr. Prasanna Santhanam received his M.B.B.S. from B.J. Medical College and his M.D. from N.H.L. Municipal Medical College. He completed a residency in internal medicine, Joan C Edwards School of Medicine, Marshall University and a fellowship in endocrinology, diabetes, and metabolism at Joan C Edwards School of Medicine, Marshall University. He underwent additional training in nuclear medicine, at the Department of Radiology and Radiological Sciences at Johns Hopkins University School of Medicine, to pursue his research and clinical interests in nuclear medicine and molecular imaging of endocrine glands and disorders. His clinical interests include thyroid disorders, endocrine neoplasms, and research focus on metabolic and molecular imaging of endocrine tissues and predictive analytics in metabolic disorders. Dr. Santhanam is rated as an Advanced provider by MediFind in the treatment of Type 2 Diabetes (T2D). His top areas of expertise are Thyroid Cancer, Follicular Thyroid Cancer, Papillary Thyroid Cancer, Anaplastic Thyroid Cancer, and Thyroidectomy.

Jonathan Rich is a primary care provider, practicing in Internal Medicine in Baltimore, Maryland. Dr. Rich is rated as a Distinguished provider by MediFind in the treatment of Type 2 Diabetes (T2D). His top areas of expertise are Heart Failure, Hypertension, Type 2 Diabetes (T2D), Heart Transplant, and Lung Transplant.

Dr. Mathioudakis, an endocrinologist and researcher, has a strong focus on diabetes management and patient care, recognized through awards like the Baltimore Top Doc. He has contributed significantly to diabetes research, authoring over 150 publications and participating in the development of consensus guidelines in the field. His studies have offered valuable insights into using health informatics for diabetes prevention and management. After graduating from the Johns Hopkins University School of Medicine and completing his training in Internal Medicine and a fellowship in Endocrinology, Diabetes, & Metabolism, Dr. Mathioudakis joined the faculty in the Division of Endocrinology, Diabetes & Metabolism in 2012. He earned a Master of Health Science in clinical investigation in 2015 and was the Clinical Director of the Division of Endocrinology from 2016 to 2021. Currently, he co-directs the Baltimore Metropolitan Diabetes Regional Partnership, focusing on improving access to diabetes prevention and management programs. As a physician-scientist, Dr. Mathioudakis leads multiple research studies funded by the NIH, private philanthropic organizations (Helmsley Charitable Trust), non-profit organizations (Breakthrough T1D), and industry. His research focuses on the effectiveness of automated diabetes prevention programs and strategies to reduce racial disparities in diabetes technology access. He also collaborates nationally to enhance care for people with type 1 diabetes. Holding a joint appointment in the Division of Biomedical Informatics and Data Science, Dr. Mathioudakis integrates machine learning and AI in diabetes research. He has served on the national Epic Endocrinology Specialty Steering Board and chaired the Type 2 Diabetes Prognostics Working Group for the Precision Medicine Diabetes Initiative. Committed to education, he frequently lectures on endocrinology, epidemiology, and health informatics. Dr. Mathioudakis is rated as a Distinguished provider by MediFind in the treatment of Type 2 Diabetes (T2D). His top areas of expertise are Type 2 Diabetes (T2D), Type 1 Diabetes (T1D), Low Blood Sugar, Maturity Onset Diabetes of the Young, and Pancreaticoduodenectomy.

Swati D Phatak, M.D., practices internal medicine at Johns Hopkins Community Physicians Greater Dundalk. She received her medical degree from Topiwala National Medical College in Mumbai, India. Dr. Phatak completed residencies at Grant Medical College University of Mumbai and at State University of New York Upstate Medical University in Syracuse, New York. She speaks English, Hindi and Marathi. Dr. Phatak is rated as an Experienced provider by MediFind in the treatment of Type 2 Diabetes (T2D). Her top areas of expertise are Vitamin D Deficiency, Hypertension, Familial Hypertension, and Glucocorticoid-Remediable Aldosteronism.

Dr. Agee is medical director for the Bayview Medical Offices. Her practice includes all aspects of primary care medicine, including prevention, pap smears and cortisone shots. Dr. Agee is from Annapolis. She attended Wake Forest University School of Medicine, in North Carolina, trained in general internal medicine at Johns Hopkins Bayview Medical Center. Dr. Agee is rated as an Experienced provider by MediFind in the treatment of Type 2 Diabetes (T2D). Her top areas of expertise are Hypertension, Familial Hypertension, Glucocorticoid-Remediable Aldosteronism, and Type 2 Diabetes (T2D).

Dr. Kendall Moseley is the Clinical Director of the Division of Diabetes, Endocrinology & Metabolism, Medical Director of the Johns Hopkins Metabolic Bone & Osteoporosis Center and Co-Director of the Johns Hopkins Multidisciplinary Parathyroid Clinic. Dr. Moseley received her medical degree from Baylor College of Medicine in Houston, TX, followed by internal medicine residency training at the Johns Hopkins Hospital. Upon completion of her endocrinology fellowship at Johns Hopkins, she joined the faculty in the Division of Endocrinology, Diabetes & Metabolism of the Johns Hopkins University School of Medicine. Dr. Moseley has a dynamic clinical practice and collaborations within the institution that focus on metabolic bone diseases, osteoporosis, hyperparathyroidism, vitamin D deficiency, atypical fractures, and skeletal survivorship. She is actively engaged in NIH-funded clinical and translational research involving the relationship between type 2 diabetes, osteoporosis, and aging. She is additionally involved in research investigating mechanisms by which chronic disease states such as malignancy, HIV, hepatitis C, and cystic fibrosis impact bone quantity and quality. Clinically, she enjoys partnering with her patients and using their unique and often complex medical history to individually tailor effective diet, lifestyle, and treatment regimens to improve skeletal health. Dr. Moseley is rated as an Experienced provider by MediFind in the treatment of Type 2 Diabetes (T2D). Her top areas of expertise are Osteoporosis, Postmenopausal Osteoporosis, Paget's Disease of Bone, and Hyperparathyroidism.

Dr. Hanyok is an associate professor of medicine and practices general internal medicine at the General Internal Medicine Practice at Bayview. Originally from Calvert County in southern Maryland, Dr. Hanyok earned a medical degree at the University of Chicago. She completed residency in internal medicine at Johns Hopkins Bayview Medical Center and additionally served as chief resident. She currently serves as Assistant Dean for Graduate Medical Education at the Johns Hopkins School of Medicine. Dr. Hanyok is rated as an Experienced provider by MediFind in the treatment of Type 2 Diabetes (T2D). Her top areas of expertise are Behcet Disease, Peripheral Artery Disease, Type 2 Diabetes (T2D), and Maturity Onset Diabetes of the Young.

Dr. Han Na Kim is a Clinical Associate and part-time Assistant Professor of Medicine in the Division of Endocrinology, Diabetes, and Metabolism. Her clinical practice focuses on metabolic bone disease, including osteoporosis and hyperparathyroidism, as well as diabetes mellitus. She earned her medical degree from the University of Chicago Pritzer School of Medicine, completed her residency in Internal Medicine at New York University, and worked as a hospitalist at University of Pittsburgh Medical Center Presbyterian/Montefiore before pursuing an endocrinology fellowship at Johns Hopkins University School of Medicine. She sees patients at the Johns Hopkins Bayview Metabolic Bone and Osteoporosis Center and Green Spring Station Johns Hopkins Endocrinology Clinic (diabetes and thyroid patients only). Dr. Kim is rated as an Experienced provider by MediFind in the treatment of Type 2 Diabetes (T2D). Her top areas of expertise are Postmenopausal Osteoporosis, Osteoporosis, Juvenile Primary Osteoporosis, and Hyperparathyroidism.

Dr. Rachel Levine is associate professor of medicine in the Department of Medicine. She completed her undergraduate and medical school degrees at McGill University in Montreal, Quebec, Canada followed by residency training in Internal Medicine at the Boston University Medical Center. She then completed fellowship in General Internal Medicine at the Johns Hopkins School of Medicine with a focus on medical education. Dr. Levine’s areas of expertise include adult learning and faculty development in teaching skills. She has vast experience designing and facilitating programs (online and live) aimed at promoting the development of scholarly educators and leaders in medical education. She currently co-directs the Longitudinal Teaching Skills Course of the Johns Hopkins Faculty Development Program (now in its 31st year) and the Johns Hopkins Summer Teaching Camp in partnership with the Institute for Excellence in Education. Dr. Levine is also co-director of the Medical Education Track of the General Internal Medicine Fellowship Program and core faculty in the Colleges Advisory Program (CAP) where she teaches and coaches medical students. Dr. Levine has presented workshops (locally, nationally and internationally) on teaching skills and other faculty development topics including career advancement and promotion for educators in the biomedical sciences. She is passionate about enhancing faculty teaching skills and promoting the academic success of educators. Dr. Levine is rated as an Experienced provider by MediFind in the treatment of Type 2 Diabetes (T2D). Her top areas of expertise are Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, Delirium, and Glucocorticoid-Remediable Aldosteronism.

Robert Mills, D.O., joins Johns Hopkins Community Physicians with many years of experience as a family medicine physician. He grew up in New Jersey and attended Villanova University for his bachelors of science in biological sciences. Upon completion, he earned his doctor of osteopathic medicine from Philadelphia College of Osteopathic Medicine. As a provider, he finds it rewarding to get to know his patients on a more personal level and help them manage their health throughout their lives. He understands medicine is challenging on both sides - for his patients and as a provider - and he knows that providing a comfortable environment, where patients feel heard and respected, is what makes a good patient-physician relationship. Dr. Mills lives with his wife in Canton and has one too many pets, including four cats and a dog. Dr. Mills is rated as an Experienced provider by MediFind in the treatment of Type 2 Diabetes (T2D). His top areas of expertise are Glucocorticoid-Remediable Aldosteronism, Familial Hypertension, Hypertension, and Familial Combined Hyperlipidemia.

Dr. Michael Fingerhood is a professor of medicine and public health at the Johns Hopkins University. His areas of clinical expertise include addiction medicine and internal medicine. He earned his M.D. from the Albert Einstein College of Medicine of Yeshiva University. He completed his residency at Johns Hopkins. Dr. Fingerhood's research interests include substance use disorders, contingency management, hepatitis C and HIV. He is a member of several professional organizations, including the American Society of Addiction Medicine, the American Academy of HIV Medicine, The Society of General Internal Medicine and the American College of Physicians. Dr. Fingerhood is rated as an Experienced provider by MediFind in the treatment of Type 2 Diabetes (T2D). His top areas of expertise are Opioid Use Disorder, HIV/AIDS, Myelitis, and AIDS Dementia Complex.

Jordan Nahas is a primary care provider, practicing in Addiction Medicine and Internal Medicine in Baltimore, Maryland. Dr. Nahas has been practicing medicine for over 10 years and is rated as an Experienced provider by MediFind in the treatment of Type 2 Diabetes (T2D). Her top areas of expertise are Legionnaire Disease, Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, and Opioid Use Disorder.

Raena Hariharan is a primary care provider, practicing in Internal Medicine in Baltimore, Maryland. Dr. Hariharan is rated as an Experienced provider by MediFind in the treatment of Type 2 Diabetes (T2D). Her top areas of expertise are Hypertensive Heart Disease, Opioid Induced Constipation, Pediatric Myocarditis, and Renovascular Hypertension.